Molecular genetics of chromosome translocations involving EWS and related family members
1Department of Biochemistry, Department of Oncology, McGill University, Montreal, Quebec, Canada H3G 1Y6.
Abstract:
Many types of sarcomas are characterized by specific chromosomal translocations that appear to result in the production of novel, tumor-specific chimeric transcription factors. Many of these show striking similarities: the emerging picture is that the amino-terminal domain of the fusion product is donated by the Ewing's sarcoma gene (EWS) or a related member from the same gene family, whereas the carboxy-terminal domain often consists of a DNA-binding domain derived from one of a number of transcription factors. Given the observation that the different translocation partners of the EWS protooncogene are associated with distinct types of sarcomas, the functional consequence of fusing EWS (or a related family member) to a different DNA-binding domain can only be understood in the context of functional studies that define the specificity of action of the different fusion products. An understanding of the molecular structure and function of these translocations provides new methods for diagnosis and novel targets for therapeutics.
Insights
Specific chromosomal translocations create novel, tumor-specific transcription factors in sarcomas. Understanding these fusion proteins, often involving the Ewing sarcoma gene (EWS), aids diagnosis and therapeutic development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Sarcomas frequently exhibit chromosomal translocations.
- These translocations generate unique, tumor-specific chimeric transcription factors.
Purpose of the Study:
- To investigate the molecular structure and function of chimeric transcription factors in sarcomas.
- To understand how EWS (Ewing sarcoma gene) fusions contribute to sarcoma development and specificity.
Main Methods:
- Analysis of chromosomal translocations in various sarcoma types.
- Functional studies to define the specificity and action of different EWS fusion products.
Main Results:
- A common pattern involves the N-terminal domain from EWS or related genes fused to a C-terminal DNA-binding domain from other transcription factors.
- Different translocation partners of EWS are linked to distinct sarcoma subtypes.
Conclusions:
- Understanding EWS fusion proteins is crucial for comprehending sarcoma pathogenesis.
- These molecular insights offer potential for improved diagnostic methods and novel therapeutic targets in sarcoma treatment.
Related Concept Videos
Crossing Over
Gene Conversion
Overview of Transposition and Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Synteny and Evolution
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral chromosome underwent...
Crossing Over


